The University of Alabama at Birmingham (UAB) is actively seeking volunteers to participate in a clinical study focused on advancing the treatment of lupus. This initiative aims to explore and evaluate novel therapeutic strategies for managing this complex autoimmune disease.
Lupus, also known as systemic lupus erythematosus (SLE), is a chronic autoimmune condition where the body's immune system attacks its own tissues and organs. This can lead to inflammation and damage in various parts of the body, including the joints, skin, kidneys, blood cells, brain, heart, and lungs. The Lupus Foundation of America estimates that lupus affects at least 1.5 million Americans, with women being disproportionately affected.
The clinical study at UAB offers an opportunity for individuals diagnosed with lupus to contribute to the development of more effective treatments. Participants will undergo thorough evaluation and monitoring as part of the study protocol. The specific details of the study, including the investigational treatment and study duration, will be provided to potential volunteers during the screening process.
Individuals interested in learning more about the lupus treatment clinical study and determining their eligibility are encouraged to contact Christina Ndolo at cmndolo@uabmc.edu.
